China Imposes Compulsory Recalls On Drug Companies (China)
This article was originally published in PharmAsia News
Executive SummaryChinese drug makers and related companies will be responsible for recalling defective drugs from the market, Chinese authorities announced. The new rule also sets up a three-class system of recalls, to separate the intensity of the recalls and how quickly the drugs must be recalled, according to its level of danger. The companies, distributors and medical institutes also must notify the government of any reports they receive of adverse reactions to their products. The new plan gives the government authority to issue the recall itself and to punish a company that breaks the rule. (Click here for more ) "China Launches Nationwide System To Recall Harmful Drugs" China Post (12/13/07)
You may also be interested in...
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.